The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Scotts Miracle-Gro's revenues will grow 10.1% and EPS will increase 51.9%.
The average estimate for revenue is $1.17 billion. On the bottom line, the average EPS estimate is $2.43.
Last quarter, Scotts Miracle-Gro booked revenue of $1.02 billion. GAAP reported sales were 13% lower than the prior-year quarter's $1.17 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
Last quarter, EPS came in at $1.60. GAAP EPS of $1.60 for Q2 were 22% lower than the prior-year quarter's $2.05 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the preceding quarter, gross margin was 37.2%, 220 basis points worse than the prior-year quarter. Operating margin was 17.0%, 200 basis points worse than the prior-year quarter. Net margin was 9.8%, 110 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $2.82 billion. The average EPS estimate is $2.53.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 212 members out of 241 rating the stock outperform, and 29 members rating it underperform. Among 95 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 86 give Scotts Miracle-Gro a green thumbs-up, and nine give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Scotts Miracle-Gro is hold, with an average price target of $44.50.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Scotts Miracle-Gro. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Scotts Miracle-Gro to My Watchlist.